Evidence map›Paper›PMID 42527797›Full record

ArticleAnnals of surgical oncology2026

ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer.

Jun Yoshino, Hakon Blomstrand, Sebastian Fjellander, Johan Svensson, Asif Halimi, Ella Kesti, Hanna Seppänen, Caroline Vilhav, Daniel Öhlund, Caj Haglund and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jun YoshinoDepartment of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
Hakon BlomstrandDepartment of Clinical Pathology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Sebastian FjellanderDepartment of Clinical Pathology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Johan SvenssonDepartment of Statistics, Umeå School of Business Economics and Statistics, Umeå University, Umeå, Sweden.
Asif HalimiDepartment of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
Ella KestiDepartment of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Hanna SeppänenDepartment of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Caroline VilhavDepartment of Transplantation Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.
Daniel ÖhlundDepartment of Diagnostics and Intervention, Oncology, and Wallenberg Centre for Molecular Medicine (WCMM), Umeå University, Umeå, Sweden.
Caj HaglundDepartment of Surgery, Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Nils O ElanderDepartment of Oncology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Peter NarediDepartment of Transplantation Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.
Malin SundDepartment of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
Oskar FranklinDepartment of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. oskar.franklin@umu.se.ORCID http://orcid.org/0000-0002-3777-6887

Funding

ALF agreement GBG-1016069Assar Gabrielsson Foundation FB24-50Assar Gabrielsson Foundation FB25-92Bengt Ihre Foundation SLS-885861Bengt Ihre Foundation SLS-960529Bengt Ihre Foundation SLS-974105Bengt Ihre Foundation SLS-986656Benny Frengens Foundation 2025CF-18Cancerforskningsfonden i Norrland AMP 24-1154Cancerforskningsfonden i Norrland LP 23-2337FORSS FORSS-1013610Juselius foundation Juselius foundation (grant no 8116Lennart Glans Stiftelse 990326Lion's Research Fund, Linköping and Region Östergötland RÖ-1006094Lion's Research Fund, Linköping and Region Östergötland RÖ-1023270Region Västerbotten RV-970069Region Västerbotten RV-979958Region Västerbotten RV-982481Region Västerbotten RV-995863Scandinavia-Japan Sasakawa Foundation GA24-JPN-0150Wilhelm and Martina Lundgren Scientific Foundation 2024-SA-4450
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42527797
PMCPMC13585846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.